» Articles » PMID: 31055565

Successful Treatment of Severe Hyperammonaemia with Ultra-High Dose Continuous Veno-Venous Haemodiafiltration

Overview
Journal Blood Purif
Specialty Hematology
Date 2019 May 6
PMID 31055565
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Hyperammonaemia is a severe condition and often requires a multimodal treatment regimen. Dialysis has been described as a potential treatment option, but currently it is not the standard of care. In this report, we describe a case of a 40-year-old postpartum woman who developed severe hyperammonaemia due to liver failure and acute kidney injury (AKI) combined with a large intra-abdominal haematoma producing nitrogen waste products. She was treated successfully with continuous veno-venous haemodiafiltration using an ultra-high effluent rate (100 mL/kg/h) and was discharged alive 32 days after the initial admission. Our report indicates that successful ammonia clearance in the setting of AKI can be obtained only by using this high effluent rate. This treatment modality should be considered in all patients with AKI and severe hyperammonaemia when other treatment modalities fail to lower ammonia levels within hours to prevent irreversible but preventable neurological damage.

Citing Articles

Severe non-hepatic hyperammonaemic encephalopathy in an immunocompromised adolescent with enterocolitis.

Borrie A, Pike M, Villeneuve S, Verma N BMJ Case Rep. 2024; 17(6).

PMID: 38901854 PMC: 11191012. DOI: 10.1136/bcr-2023-256225.


Mixed mode of artificial liver support in patients with acute-on-chronic liver failure: a retrospective cohort study.

Wang X, Peng B, Zhang L, Zhao J, Zhang L, Ren H Hepatol Int. 2023; 17(5):1241-1250.

PMID: 37550499 DOI: 10.1007/s12072-023-10573-2.


Hepatic Arterioportal Fistula Following Liver Trauma: Case Series and Review of the Literature.

Noorbakhsh S, Gomez L, Joung Y, Meyer C, Hanos D, Freedberg M Vasc Endovascular Surg. 2023; 57(7):749-755.

PMID: 36940466 PMC: 10724846. DOI: 10.1177/15385744231165155.


Kinetics of Bilirubin and Ammonia Elimination during Hemadsorption Therapy in Secondary Sclerosing Cholangitis Following ECMO Therapy and Severe COVID-19.

Tampe D, Korsten P, Bremer S, Winkler M, Tampe B Biomedicines. 2021; 9(12).

PMID: 34944657 PMC: 8698542. DOI: 10.3390/biomedicines9121841.

References
1.
Slack A, Auzinger G, Willars C, Dew T, Musto R, Corsilli D . Ammonia clearance with haemofiltration in adults with liver disease. Liver Int. 2013; 34(1):42-8. DOI: 10.1111/liv.12221. View

2.
Gupta S, Fenves A, Hootkins R . The Role of RRT in Hyperammonemic Patients. Clin J Am Soc Nephrol. 2016; 11(10):1872-1878. PMC: 5053785. DOI: 10.2215/CJN.01320216. View

3.
Cardoso F, Gottfried M, Tujios S, Olson J, Karvellas C . Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2017; 67(2):711-720. PMC: 5832542. DOI: 10.1002/hep.29488. View